Bellerophon Therapeutics, Inc. in its Annual meeting of shareholders held on June 1, 2022 elected Mary Ann Cloyd and Crispin Teufel to serve on the Company's board of directors for a three-year term until the Company's 2025 annual meeting of stockholders and until each of their respective successors is duly elected and qualified.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0563 USD | -13.38% | 0.00% | +52.16% |
May. 02 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+52.16% | 689K | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.67% | 21.97B | |
-4.64% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- BLPH Stock
- News Bellerophon Therapeutics, Inc.
- Bellerophon Therapeutics, Inc. Announces New Board Appointment